SOD2 and Parkinson disease: Genetic deletion results in profound neurological deficits and early mortality [197], while reduced MnSOD expression is commonly observed in conditions such as epilepsy, Huntington’s disease, ischemic stroke, Parkinson’s disease, and Alzheimer’s disease [198,202,204,211,215].